Send to

Choose Destination
J Biol Chem. 2015 Feb 27;290(9):5661-72. doi: 10.1074/jbc.M114.618835. Epub 2015 Jan 2.

Efficient delivery and functional expression of transfected modified mRNA in human embryonic stem cell-derived retinal pigmented epithelial cells.

Author information

From the Center of Regenerative Medicine in Barcelona, 08003 Barcelona, Spain,
From the Center of Regenerative Medicine in Barcelona, 08003 Barcelona, Spain.
From the Center of Regenerative Medicine in Barcelona, 08003 Barcelona, Spain, the Universitat de Barcelona, 08007 Barcelona, Spain, and.
the Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, 92037 California


Gene- and cell-based therapies are promising strategies for the treatment of degenerative retinal diseases such as age-related macular degeneration, Stargardt disease, and retinitis pigmentosa. Cellular engineering before transplantation may allow the delivery of cellular factors that can promote functional improvements, such as increased engraftment or survival of transplanted cells. A current challenge in traditional DNA-based vector transfection is to find a delivery system that is both safe and efficient, but using mRNA as an alternative to DNA can circumvent these major roadblocks. In this study, we show that both unmodified and modified mRNA can be delivered to retinal pigmented epithelial (RPE) cells with a high efficiency compared with conventional plasmid delivery systems. On the other hand, administration of unmodified mRNA induced a strong innate immune response that was almost absent when using modified mRNA. Importantly, transfection of mRNA encoding a key regulator of RPE gene expression, microphthalmia-associated transcription factor (MITF), confirmed the functionality of the delivered mRNA. Immunostaining showed that transfection with either type of mRNA led to the expression of roughly equal levels of MITF, primarily localized in the nucleus. Despite these findings, quantitative RT-PCR analyses showed that the activation of the expression of MITF target genes was higher following transfection with modified mRNA compared with unmodified mRNA. Our findings, therefore, show that modified mRNA transfection can be applied to human embryonic stem cell-derived RPE cells and that the method is safe, efficient, and functional.


Differentiation; Embryonic Stem Cell; Induced Pluripotent Stem Cell (iPS Cell, iPSC); Modified mRNA; Retinal Pigmented Epithelial Cell; Transfection; mRNA

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center